Stifel Nicolaus initiated coverage on shares of Life360 (NASDAQ:LIF – Free Report) in a research note issued to investors on Tuesday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $37.00 target price on the stock.
A number of other equities research analysts have also weighed in on the stock. Canaccord Genuity Group assumed coverage on shares of Life360 in a report on Monday, June 17th. They set a buy rating and a $40.00 price objective for the company. Evercore ISI raised shares of Life360 to a strong-buy rating and set a $37.00 target price on the stock in a research report on Monday, June 17th. UBS Group raised shares of Life360 to a hold rating and set a $32.00 target price on the stock in a research report on Monday, June 17th. JMP Securities assumed coverage on shares of Life360 in a research report on Thursday, June 20th. They set an outperform rating and a $38.00 target price on the stock. Finally, Loop Capital raised shares of Life360 to a strong-buy rating and set a $36.00 target price on the stock in a research report on Monday, June 17th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of Buy and an average target price of $37.14.
Check Out Our Latest Analysis on LIF
Life360 Price Performance
Life360 Company Profile
Life360 Inc is a family connection and safety company. Its business category includes mobile app and Tile tracking devices with a range of services, including location sharing, safe driver reports and crash detection with emergency dispatch. Life360 Inc is based in SAN FRANCISCO.
See Also
- Five stocks we like better than Life360
- What is the S&P/TSX Index?
- RXO Shares Surge Following New Acquisition Deal
- Industrial Products Stocks Investing
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Life360 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Life360 and related companies with MarketBeat.com's FREE daily email newsletter.